Back to Trades
KALAWADIA MILAN KANTILAL
CEO - North AmericaCIK 0002125028
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 1
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2026
KALAWADIA MILAN KANTILAL, CEO - North America, has filed 1 SEC report (2026), all concentrated in DR REDDYS LABORATORIES LTD (RDY), totaling $0 in disclosed volume. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
1 loaded
| Apr 1 | RDY DR REDDYS LABORATORIES LTD | KALAWADIA MILAN KANTILAL | CEO - North America | Other | $0 |
1 filing